These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22137542)

  • 1. High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms.
    Chiu AF; Liao CH; Wang CC; Wang JH; Tsai CH; Kuo HC
    Urology; 2012 Feb; 79(2):260-5. PubMed ID: 22137542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
    Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
    Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.
    Hsiao SM; Lin HH; Kuo HC
    Int Urogynecol J; 2013 Feb; 24(2):263-7. PubMed ID: 22588143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary incontinence and overactive bladder in patients with heart failure.
    Palmer MH; Hardin SR; Behrend C; Collins SK; Madigan CK; Carlson JR
    J Urol; 2009 Jul; 182(1):196-202. PubMed ID: 19447424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between metabolic syndrome and male overactive bladder in a Japanese population based on three different sets of criteria for metabolic syndrome and the Overactive Bladder Symptom Score.
    Ohgaki K; Horiuchi K; Kondo Y
    Urology; 2012 Jun; 79(6):1372-8. PubMed ID: 22656415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).
    Coyne KS; Barsdorf AI; Thompson C; Ireland A; Milsom I; Chapple C; Kopp ZS; Bavendam T
    Neurourol Urodyn; 2012 Apr; 31(4):448-54. PubMed ID: 22396308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
    Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
    Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the urinary status by self-administered questionnaires in men after radical prostatectomy-- comparison with the urination status of elderly women].
    Taoka R; Shimada O; Kitamura Y; Okazoe H; Taniguchi S; Tsunemori H; Wu X; Inui M; Sugimoto M; Kakehi Y
    Hinyokika Kiyo; 2008 Nov; 54(11):717-22. PubMed ID: 19068725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
    Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of overactive bladder symptom on quality of life in stroke patients.
    Itoh Y; Yamada S; Konoeda F; Koizumi K; Nagata H; Oya M; Suzuki N
    Neurourol Urodyn; 2013 Jun; 32(5):428-34. PubMed ID: 23129306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.
    Liao CH; Chung SD; Kuo HC
    Int J Clin Pract; 2011 May; 65(5):552-8. PubMed ID: 21489080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between the self-perception period of overactive bladder symptoms and overactive bladder symptom scores in a non-treated population and related sociodemographic and lifestyle factors.
    Kim JH; Ham BK; Shim SR; Lee WJ; Kim HJ; Kwon SS; Bae JH
    Int J Clin Pract; 2013 Aug; 67(8):795-800. PubMed ID: 23869680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower urinary tract symptoms in patients with Niigata Minamata disease: a case-control study 50 years after methyl mercury pollution.
    Hara N; Saito H; Takahashi K; Takeda M
    Int J Urol; 2013 Jun; 20(6):610-5. PubMed ID: 23163739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey.
    Zumrutbas AE; Bozkurt AI; Tas E; Acar CI; Alkis O; Coban K; Cetinel B; Aybek Z
    Int J Urol; 2014 Oct; 21(10):1027-33. PubMed ID: 24931070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.